{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:40:43Z","timestamp":1760028043846,"version":"3.40.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJEM"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incidence of HIV infections in Canada has increased yearly since 2014. New cases of HIV have resulted almost exclusively from non-occupational exposures, including sexual contact and needle sharing. Appropriate HIV post-exposure prophylaxis is under-prescribed to patients who present to the emergency department after a high-risk exposure. In November of 2017, a Canadian guideline on HIV pre-exposure prophylaxis (PrEP) and non-occupational post-exposure prophylaxis (nPEP) was published. The guideline presents a standardized, evidence-based approach to assessing risk for HIV transmission and prescribing HIV prophylaxis. This summary highlights the key points from the guideline that are relevant to the practice of emergency medicine in Canada.<\/jats:p>","DOI":"10.1017\/cem.2018.462","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T11:04:41Z","timestamp":1542711881000},"page":"21-25","source":"Crossref","is-referenced-by-count":6,"title":["New Canadian guideline provides evidence-based approach to non-occupational HIV prophylaxis"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-2331","authenticated-orcid":false,"given":"Shannon","family":"O\u2019Donnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrell H. S.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"S1481803518004621_ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"S1481803518004621_ref14","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000298"},{"volume-title":"Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV\u2013United States, 2016","year":"2016","author":"Dominguez","key":"S1481803518004621_ref12"},{"key":"S1481803518004621_ref10","unstructured":"Guidelines version 8.2 January 2017. London, UK: European AIDS Clinical Society; 2017."},{"key":"S1481803518004621_ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.8900"},{"key":"S1481803518004621_ref4","first-page":"1","article-title":"Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services","volume":"54","author":"Smith","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"S1481803518004621_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(03)00338-X"},{"key":"S1481803518004621_ref8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S2055-6640(20)30338-1","article-title":"Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines","volume":"3","author":"Wright","year":"2017","journal-title":"J Virus Erad"},{"key":"S1481803518004621_ref6","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170494"},{"key":"S1481803518004621_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2016.03.027"},{"key":"S1481803518004621_ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ093"},{"key":"S1481803518004621_ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.5148"},{"key":"S1481803518004621_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04331-2"},{"key":"S1481803518004621_ref11","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"volume-title":"Consultation version of the BHIVA\/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP)","year":"2017","author":"Brady","key":"S1481803518004621_ref7"},{"key":"S1481803518004621_ref1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v43i12a01"},{"key":"S1481803518004621_ref2","first-page":"1245","article-title":"Notes from the field: occupationally acquired HIV infection among health care workers \u2013 United States, 1985\u20132013","volume":"63","author":"Joyce","year":"2015","journal-title":"MMWR Mort Wkly Rep"}],"container-title":["CJEM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1481803518004621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T23:54:11Z","timestamp":1609458851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1481803518004621\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1481803518004621"],"URL":"https:\/\/doi.org\/10.1017\/cem.2018.462","relation":{},"ISSN":["1481-8035","1481-8043"],"issn-type":[{"type":"print","value":"1481-8035"},{"type":"electronic","value":"1481-8043"}],"subject":[],"published":{"date-parts":[[2018,11,20]]}}}